Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
GH35
i
Other names:
GH35
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Genhouse Bio
Drug class:
KRAS G12C inhibitor
Related drugs:
‹
sotorasib (76)
adagrasib (35)
RG6330 (6)
D-1553 (6)
fulzerasib (4)
ZG19018 (4)
JAB-21822 (4)
APG-1842 (3)
ARS-1620 (2)
BI 1823911 (2)
MK-1084 (2)
JDQ443 (2)
ABSK071 (1)
AZ’8037 (1)
GEC-255 (1)
RM-029 (1)
YL-17231 (1)
D3S-001 (0)
FWD-K01 (0)
HBI-2438 (0)
HS-10370 (0)
JNJ-74699157 (0)
LY3499446 (0)
RMC-6291 (0)
UCT-001024 (0)
VRTX126 (0)
YL-15293 (0)
LY3537982 (0)
sotorasib (76)
adagrasib (35)
RG6330 (6)
D-1553 (6)
fulzerasib (4)
ZG19018 (4)
JAB-21822 (4)
APG-1842 (3)
ARS-1620 (2)
BI 1823911 (2)
MK-1084 (2)
JDQ443 (2)
ABSK071 (1)
AZ’8037 (1)
GEC-255 (1)
RM-029 (1)
YL-17231 (1)
D3S-001 (0)
FWD-K01 (0)
HBI-2438 (0)
HS-10370 (0)
JNJ-74699157 (0)
LY3499446 (0)
RMC-6291 (0)
UCT-001024 (0)
VRTX126 (0)
YL-15293 (0)
LY3537982 (0)
›
Associations
News
Trials
Filter by
Latest
7ms
Dose Finding Study of GH35 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
P1, N=18, Active, not recruiting, Suzhou Genhouse Bio Co., Ltd. | Recruiting --> Active, not recruiting | N=38 --> 18
7 months ago
Enrollment closed • Enrollment change
|
KRAS (KRAS proto-oncogene GTPase)
|
GH35
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login